Iowa Diabetes Partners with Eversense 365 to Provide the First One-Year CGM to Patients

(November 12, 2024) – Iowa Diabetes is excited to announce that it is now a certified site in Iowa to offer the groundbreaking Eversense 365 continuous glucose monitoring (CGM) system to its patients. Developed by Senseonics and Acscensia Diabetes Care, Eversense 365 is the world’s first CGM that provides accurate glucose monitoring for a full year with just one sensor.

Unlike traditional CGMs that require frequent sensor replacements every 10-15 days, the Eversense 365 system offers a hassle-free experience with a single sensor lasting 365 days. This reduces the burden of device management and provides patients with uninterrupted, reliable glucose data.

Designed to reduce the day-to-day stress of diabetes management, Eversense 365 represents a revolutionary advancement in diabetes technology.

“With only one CGM replacement a year, fewer failed or wasted sensors, and alerts you can trust, Eversense 365 allows patients to live life uninterrupted by their diabetes technology. We can’t wait to get this game-changing product to people with diabetes and healthcare providers across the country.” said Brian Hansen, President of CGM at Ascensia Diabetes Care, a subsidiary of PHC Holdings Corporation (TSE 6523).

What Sets Eversense 365 Apart from Other CGMs:
* Longest Lasting CGM: One sensor lasts for a full year, minimizing the need for frequent replacements.
* High Accuracy: Provides consistent and accurate glucose readings, helping patients maintain better glucose control.
* Reduced Disruptions: Fewer sensor changes mean less interruption to daily life and more focus on managing diabetes effectively.

Whitney Ceretti, PA-C at Iowa Diabetes shares, “I’m excited for patients with diabetes to have one more tool to help them manage their diabetes. With so many factors affecting blood sugar, it’s so amazing that we can provide patients with a resource to make the disease feel a little less overwhelming. Eversense is a CGM option like none other in the market, and it gives our patients the option to choose what works best for them! The procedure is quick and easy, and as a fellow individual with diabetes, it is an honor to be able to provide this service!”

What Patients Say: “Managing diabetes can be hard work. When I was first diagnosed with type 1 diabetes, I spent a lot of time struggling to gain control and a big part of that was finding the right technology for my lifestyle,” says Troy Ita, a devoted family man, automotive sales coach and Eversense ambassador. “With traditional CGMs, I felt like I was managing both my diabetes and my technology. Frequent CGM interruptions are frustrating, expensive and time consuming, and the disruption was distracting me from important things like my family. With just one CGM needed for one year, Eversense 365 is going to significantly reduce the burden of managing diabetes, and I can’t wait to get started.”

The Eversense 365 system has been cleared by the U.S. Food and Drug Administration (FDA) for use in people with Type 1 and Type 2 diabetes aged 18 years and older.

-30-

Notes for Editors:

About Iowa Diabetes: Iowa Diabetes is a leading research center dedicated to providing specialized diabetes care, education, and support through clinical research and technology. Our mission is to improve the lives of people with diabetes through cutting-edge treatment opportunities. On World Diabetes Day 2024, taking one more step to put our mission into action, we are excited to be offering Eversense 365 to patients at our diabetes clinic. With a team of fun, experienced, and expert healthcare professionals, Iowa Diabetes is at the forefront of diabetes research and patient care.

For more information, call 515-329-6800 or email info@iowadiabetes.com